Araceli Biosciences
TIGARD, Oregon · Biotechnology, Healthcare
Araceli Biosciences is transforming therapeutic discovery with technologies built for speed, precision, and impact. Our advanced High Content Imaging platforms deliver real-time analysis, giving researchers immediate, actionable answers during experiments. Responding at the pace of biology accelerates decision-making, improves candidate selection, and reduces costly downstream failures.
Key facts
- Headquarters
- TIGARD, Oregon
- Employees
- 45
- Industries
- Biotechnology, Healthcare
- Status
- Private
- Website
- aracelibio.com
- Company page
Recent activity at Araceli Biosciences
- : Araceli Biosciences launched Endeavor® Live Cell, an ultra-high-throughput kinetic imaging solution for drug discovery.
- : Araceli Biosciences Appoints Christine A. Tsingos to Chief Financial Officer
- : Araceli Biosciences
- : Araceli Biosciences raises $11.2M in Seed financing to accelerate drug discovery innovations, led by several investors.
- : Araceli Biosciences
- : Araceli Biosciences Appoints Matt Beaudet as President and CEO
- : Araceli Biosciences
Araceli Biosciences funding history
| Date | Round | Amount |
|---|---|---|
| Dec 2025 | Venture | $12.2M |
| Apr 2025 | Seed | $11.2M |
| Jan 2025 | Seed | $2.5M |
| Apr 2023 | Seed | $12.2M |
Leadership
- Jonathan Day, Vice President WW Sales and Support
- Christine A. Tsingos, Chief Financial Officer
- Kirk Malloy, Director
- Sean O'Neill, Director
- Kevin Gabelein, Director
- J. Freytag, Director
- William Cortelyou, Director
- Shawn Macdonald, Chief Financial Officer
- Matt Beaudet, Chief Executive Officer
Verified email and direct lines for Araceli Biosciences’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Employee benefit plans
Araceli Biosciences files 1 employee benefit plan with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
Araceli Biosciences in the news
- Araceli Biosciences Launches Endeavor® Live Cell for Ultra-High-Throughput Kinetic Imaging in AI-Driven Drug Discovery - BioSpace (May 20, 2026)
- Araceli Biosciences and Ginkgo Bioworks Bring Cellular Imaging at Scale to Nebula's Lab-in-the-Loop - Nasdaq (Oct 08, 2026)
- VALID Therapeutics Partners With Araceli Biosciences to Advance AI-Driven Drug Discovery - BioSpace (Jan 22, 2025)
Companies similar to Araceli Biosciences
- Pyxis Oncology, Inc. · Biotechnology, Healthcare
- IntelGenx Technologies Corp. · Biotechnology, Healthcare
- Curevo · Biotechnology, Healthcare
- Shape Memory Medical · Biotechnology, Healthcare
- Adagio Medical · Biotechnology, Healthcare
About Araceli Biosciences: questions and answers
What does Araceli Biosciences do?
Araceli Biosciences is transforming therapeutic discovery with technologies built for speed, precision, and impact. Our advanced High Content Imaging platforms deliver real-time analysis, giving researchers immediate, actionable answers during experiments. Responding at the pace of biology accelerates decision-making, improves candidate selection, and reduces costly downstream failures.
Where is Araceli Biosciences headquartered?
Araceli Biosciences is headquartered in TIGARD, Oregon.
How many employees does Araceli Biosciences have?
Araceli Biosciences has about 45 employees.
Has Araceli Biosciences raised funding?
Yes. Fundz has recorded 4 funding events for Araceli Biosciences. The most recent, $12.2M, was in Dec 2025.
Who leads Araceli Biosciences?
Jonathan Day is a Vice President WW Sales and Support at Araceli Biosciences.
What is the latest news on Araceli Biosciences?
On May 20, 2026, Araceli Biosciences launched Endeavor® Live Cell, an ultra-high-throughput kinetic imaging solution for drug discovery.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy